Is that right? I thought SPI-1005 is in phase 2 trials. It seems to do a good job for people with Ménière's (30% lower T for most patients!). We only need to wait for results for people who have regular T (e.g. NIHL). So in that sense, I too am hopeful, albeit moderately so